US Patent 11248253 Methods using randomer-containing synthetic molecules
Patent 11248253 was granted and assigned to Adaptive Biotechnologies on February, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Article (+199 characters)
Article
Patent abstract
Methods are provided for correction of amplification bias and quantitation of adaptive immune cells in a sample using synthetic templates that include random oligonucleotide sequences.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
112482530
Date of Patent
February 15, 2022
0Patent Application Number
168644080
Date Filed
May 1, 2020
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
112482530
Date of Patent
February 15, 2022
0Patent Application Number
168644080
Date Filed
May 1, 2020
0Official Website
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 16 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11248253 Methods using randomer-containing synthetic molecules
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11248253
Date of patent
February 15, 2022
Patent application number
16864408
Date Filed
May 1, 2020
Patent primary examiner
Find more entities like US Patent 11248253 Methods using randomer-containing synthetic molecules
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.